Findings seen in patients following myocardial infarction. (HealthDay News) — Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction ...

Researchers at the University of Virginia School of Medicine say this finding could open the door to better ways to manage ...

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

Objectives Elevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Kidney failure deaths in Maharashtra have doubled from 2018 to 2023, with those aged 45 and above being most at risk. Experts ...

In patients with NSTEMI, OHS was associated with higher mortality, cardiac arrest, AKI, renal replacement therapy, and respiratory failure requiring intubation. Obesity hypoventilation syndrome (OHS) ...

Using pooled, weighted Behavioral Risk Factor Surveillance System data from 23 states (2020–2022) Waters and colleagues revealed that LGBTQ+ cancer survivors had significantly higher age-adjusted ...